Cargando…
Sequential Treatment of Biliary Atresia With Kasai Hepatoportoenterostomy and Liver Transplantation: Benefits, Risks, and Outcome in 393 Children
Introduction: Surgical treatment of biliary atresia (BA) is still based on sequential strategy with Kasai hepatoportoenterostomy (KP) followed by liver transplantation (LT), in case of complicated secondary biliary cirrhosis. Concerns have been expressed regarding the risks of LT related to previous...
Autores principales: | Tambucci, Roberto, de Magnée, Catherine, Szabo, Margot, Channaoui, Aniss, Pire, Aurore, de Meester de Betzenbroeck, Vanessa, Scheers, Isabelle, Stephenne, Xavier, Smets, Françoise, Sokal, Etienne M., Reding, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292612/ https://www.ncbi.nlm.nih.gov/pubmed/34307260 http://dx.doi.org/10.3389/fped.2021.697581 |
Ejemplares similares
-
Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?
por: de Magnée, Catherine, et al.
Publicado: (2021) -
Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel
por: Calinescu, Ana M., et al.
Publicado: (2022) -
Clinical Benefit of Liver Stiffness Measurement at 3 Months after Kasai Hepatoportoenterostomy to Predict the Liver Related Events in Biliary Atresia
por: Hahn, Seung Min, et al.
Publicado: (2013) -
A Nomogram Predicting the Prognosis of Children With Biliary Atresia After Hepatoportoenterostomy
por: Liu, Jin-qiao, et al.
Publicado: (2021) -
Everolimus is Safe as a Second-/Third-Line Therapy in Pediatric Autoimmune Hepatitis
por: Jannone, Giulia, et al.
Publicado: (2022)